resource source identifier antibodies jo urn al pr e p roo f 22 cd9 cst (Cell Signaling Technology Inc)
Structured Review
Resource Source Identifier Antibodies Jo Urn Al Pr E P Roo F 22 Cd9 Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/als-cst/10__1016_slash_j__isci__2026__115069-215-10-23
Average 86 stars, based on 1 article reviews
Images
Related Articles
Magnetic Resonance Imaging:Article Title: Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity. Article Snippet: The pathological hallmarks of amyotrophic lateral sclerosis (ALS) are degeneration of the primary motor cortex grey matter (GM) and corticospinal tract (CST) resulting in upper motor neuron (UMN) dysfunction.. Conventional brain magnetic resonance imaging (MRI) shows abnormal CST hyperintensity in some UMN-predominant ALS patients (ALS-CST+) but not in others (ALS-CST–).. In addition to the CST differences, we aimed to determine whether GM degeneration differs between ALS-CST+ and ALS-CST– patients by cortical thickness (CT), voxelbased morphometry (VBM) and fractal dimension analyses. Article Title: Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes Article Snippet: Similar reductions in Article Title: Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Article Snippet: Voxel based morphometry (VBM) allows objective and automated detection of structural changes in brains of patients with amyotrophic lateral sclerosis (ALS).. We investigated whether VBM could identify cortical atrophy from T1-weighted images obtained during routine 1.5T studies of ALS patients with various clinically defi ned phenotypes.. For this purpose T1-weighted brain MRI was obtained at 1.5T during routine clinical study in neurologic disease controls ( n 15) and ALS patients ( n 88) categorized into four subgroups based on their clinical phenotypes: predominant upper motor neuron (UMN) dysfunction with or without corticospinal tract (CST) hyperintensity (ALS-CST / – ), combined UMN and prominent lower motor neuron (LMN) dysfunction (classic ALS), and frontotemporal dementia (ALS-FTD). Article Title: Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes Article Snippet: Differences in the DTT findings between the two groups are supplemented by clinical observations of significantly shorter duration of symptoms prior to MRI in the Article Title: Quantitative Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study. Article Snippet: Considering clinical, GM, and WM features independently, the following accuracies were observed: (1) clinical measures alone provided an accuracy of 55% when considering all Biomarker Discovery:Article Title: Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity. Article Snippet: The pathological hallmarks of amyotrophic lateral sclerosis (ALS) are degeneration of the primary motor cortex grey matter (GM) and corticospinal tract (CST) resulting in upper motor neuron (UMN) dysfunction.. Conventional brain magnetic resonance imaging (MRI) shows abnormal CST hyperintensity in some UMN-predominant ALS patients (ALS-CST+) but not in others (ALS-CST–).. In addition to the CST differences, we aimed to determine whether GM degeneration differs between ALS-CST+ and ALS-CST– patients by cortical thickness (CT), voxelbased morphometry (VBM) and fractal dimension analyses. Article Title: Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes Article Snippet: Similar reductions in Article Title: Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Article Snippet: Voxel based morphometry (VBM) allows objective and automated detection of structural changes in brains of patients with amyotrophic lateral sclerosis (ALS).. We investigated whether VBM could identify cortical atrophy from T1-weighted images obtained during routine 1.5T studies of ALS patients with various clinically defi ned phenotypes.. For this purpose T1-weighted brain MRI was obtained at 1.5T during routine clinical study in neurologic disease controls ( n 15) and ALS patients ( n 88) categorized into four subgroups based on their clinical phenotypes: predominant upper motor neuron (UMN) dysfunction with or without corticospinal tract (CST) hyperintensity (ALS-CST / – ), combined UMN and prominent lower motor neuron (LMN) dysfunction (classic ALS), and frontotemporal dementia (ALS-FTD). Article Title: Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes Article Snippet: Differences in the DTT findings between the two groups are supplemented by clinical observations of significantly shorter duration of symptoms prior to MRI in the Article Title: Quantitative Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study. Article Snippet: Considering clinical, GM, and WM features independently, the following accuracies were observed: (1) clinical measures alone provided an accuracy of 55% when considering all |

